Earnings Feed
Start Free
CONMED Corp·4

Jun 3, 4:12 PM ET

Farkas Charles 4

4 · CONMED Corp · Filed Jun 3, 2026

Research Summary

AI-generated summary of this filing

Updated

CONMED (CNMD) Director Charles Farkas Receives RSUs, Exercises 668 Shares

What Happened Charles Farkas, a director of CONMED Corporation (CNMD), was granted 5,772 restricted stock units (RSUs) on 2026-06-01 (reported on a Form 4 filed 2026-06-03). The filing also reports exercise/conversion of 668 derivative shares on 2026-06-02 (an acquisition entry) and a matching disposition of 668 shares the same day. All reported transactions show $0.00 per share and $0 total value in the filing.

Key Details

  • Transactions reported:
    • 2026-06-01 — Grant/Award (code A): 5,772 RSUs @ $0.00 (acquired).
    • 2026-06-02 — Exercise/Conversion (code M): 668 shares @ $0.00 (acquired).
    • 2026-06-02 — Exercise/Conversion (code M): 668 shares @ $0.00 (disposed).
  • Footnotes: Each RSU represents a contingent right to one share under CONMED’s 2025 Long-Term Incentive Plan; RSUs generally vest 100% after one year (per footnotes F1/F2).
  • Filing: Form 4 filed 2026-06-03 for transactions dated 2026-06-01 and 2026-06-02 — filing appears timely based on provided dates.
  • Shares owned after the transactions are not specified in the provided excerpt.

Context

  • The 5,772-item entry is an RSU award (an acquisition of a contingent right to shares) and will convert to common stock only upon vesting per the plan terms.
  • The filing shows an equal acquisition and disposition of 668 shares on the same day; that pattern frequently reflects an immediate sale following conversion/vesting or tax-related withholding, but the Form 4 here does not state the reason.
  • Awards and conversions can be routine compensation actions and do not by themselves signal management’s view of the company’s stock price.

Insider Transaction Report

Form 4
Period: 2026-06-01
CONMED CorpCNMD
Farkas Charles
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2026-06-02+668→ 15,527 total
  • Award

    RSUs (Restricted Stock Units)

    [F1]
    2026-06-01+5,772→ 5,772 total
    Exercise: $0.00From: 2027-06-01Exp: 2036-06-01→ Common Stock (5,772 underlying)
  • Exercise/Conversion

    RSUs (Restricted Stock Units)

    [F2]
    2026-06-02−668→ 0 total
    Exercise: $0.00From: 2026-06-02Exp: 2035-06-02→ Common Stock (668 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
  • [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period.
Signature
/s/ Thomas Fistek for Charles Farkas by Power of Attorney|2026-06-03

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT